Abstract
HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture of R5-tropic and X4-tropic HIV (dual/mixed, DM HIV). The level of infectivity for R5 virus (R5-RLU) varies among HIVinfected infants. HIV tropism and R5-RLU were measured in samples from HIV-infected Ugandan infants using a commercial assay. DM HIV was detected in 7/72 (9.7%) infants at the time of HIV diagnosis (birth or 6-8 weeks of age, 4/15 (26.7%) with subtype D, 3/57 (5.3 %) with other subtypes, P=0.013). A transition from R5-tropic to DM HIV was observed in only two (6.7%) of 30 infants over 6-12 months. Six (85.7%) of seven infants with DM HIV died, compared to 21/67 (31.3%) infants with R5-tropic HIV (p=0.09). Higher R5-RLU at 6-8 weeks was not associated with decreased survival. Infants with in utero infection had a higher median R5-RLU than infants who were HIV-uninfected at birth (p=0.025).
Keywords: CCR5, CXCR4, HIV-1, infant, survival, transmission, tropism, HIV, Ugandan Infants, HIV-infected infants, CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, R5-tropic, X4-tropic HIV, R5 virus, R5-RLU, CD4, T cell-tropic virus, chronic HIV infection, dual-tropic HIV, AIDS, single dose nevirapine, sdNVP, pMTCT), HIVNET, HIV Tropism, retroviral vector, HEK 293 cells, pseudoviruses, U87 cells, HIV pol subtype, Wilcoxon rank test, Fisher's exact test), human immunodeficiency virus type 1-infected mothers, V3 regions, HIV-1 subtypes
Current HIV Research
Title: Analysis of HIV Tropism in Ugandan Infants
Volume: 8 Issue: 7
Author(s): Clemensia Nakabiito, Susan H. Eshleman, Mary Glenn Fowler, Michelle McConnell, Flavia Matovu, Paul M. Bakaki, Allan Taylor, Laura A. Guay, Chineta Eure, Jessica D. Church, Deborah Donnell, Saad B. Omer, Danstan Bagenda, J. Brooks Jackson, Philippa Musoke, Anthony Mwatha and Wei Huang
Affiliation:
Keywords: CCR5, CXCR4, HIV-1, infant, survival, transmission, tropism, HIV, Ugandan Infants, HIV-infected infants, CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, R5-tropic, X4-tropic HIV, R5 virus, R5-RLU, CD4, T cell-tropic virus, chronic HIV infection, dual-tropic HIV, AIDS, single dose nevirapine, sdNVP, pMTCT), HIVNET, HIV Tropism, retroviral vector, HEK 293 cells, pseudoviruses, U87 cells, HIV pol subtype, Wilcoxon rank test, Fisher's exact test), human immunodeficiency virus type 1-infected mothers, V3 regions, HIV-1 subtypes
Abstract: HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture of R5-tropic and X4-tropic HIV (dual/mixed, DM HIV). The level of infectivity for R5 virus (R5-RLU) varies among HIVinfected infants. HIV tropism and R5-RLU were measured in samples from HIV-infected Ugandan infants using a commercial assay. DM HIV was detected in 7/72 (9.7%) infants at the time of HIV diagnosis (birth or 6-8 weeks of age, 4/15 (26.7%) with subtype D, 3/57 (5.3 %) with other subtypes, P=0.013). A transition from R5-tropic to DM HIV was observed in only two (6.7%) of 30 infants over 6-12 months. Six (85.7%) of seven infants with DM HIV died, compared to 21/67 (31.3%) infants with R5-tropic HIV (p=0.09). Higher R5-RLU at 6-8 weeks was not associated with decreased survival. Infants with in utero infection had a higher median R5-RLU than infants who were HIV-uninfected at birth (p=0.025).
Export Options
About this article
Cite this article as:
Nakabiito Clemensia, H. Eshleman Susan, Glenn Fowler Mary, McConnell Michelle, Matovu Flavia, M. Bakaki Paul, Taylor Allan, A. Guay Laura, Eure Chineta, D. Church Jessica, Donnell Deborah, B. Omer Saad, Bagenda Danstan, Brooks Jackson J., Musoke Philippa, Mwatha Anthony and Huang Wei, Analysis of HIV Tropism in Ugandan Infants, Current HIV Research 2010; 8 (7) . https://dx.doi.org/10.2174/157016210793499187
DOI https://dx.doi.org/10.2174/157016210793499187 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV vaccine development
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
Lymphomas in people living with HIV (PLWH)
In the era of combined antiretroviral therapy (cART), the incidence of lymphoma among people living with HIV (PLWH) surpassed Kaposi's sarcoma in 2011, becoming the most common AIDS-defining malignancy. The annual incidence rate ranges approximately from 100 to 300 per 100,000 individuals with HIV infection as the population denominator, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review on Development and Characterization of a Cost-effective Targeted Quality-driven Antimalarial Product with an Emphasis on Phytosomes
Current Drug Targets Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth
Current Pediatric Reviews AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases
Current Gene Therapy Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Mechanisms Involved in the Anti-Inflammatory Properties of Native and Genetically Engineered Lactic Acid Bacteria
Anti-Infective Agents Plasma Steroid Level Measured Using Modern Separation Techniques as Biomarkers in Biological Diagnostics
Current Pharmaceutical Analysis Medicinal Chemistry of Drugs with Active Metabolites Following Conjugation
Mini-Reviews in Medicinal Chemistry Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood
Current Pediatric Reviews Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry In vivo Fluorescence Detection in Surgery: A Review of Principles, Methods, and Clinical Applications
Current Medical Imaging Anti-inflammatory Effects of Dietary Antioxidants
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders
Current Drug Targets Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets
Current Medicinal Chemistry Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design Recent Advances in Hematopoietic Stem Cell-Mediated Regeneration
Recent Patents on Regenerative Medicine The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)
Current Medicinal Chemistry Applications of Cellulose-based Materials in Sustained Drug Delivery Systems
Current Medicinal Chemistry Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews